(July 29, 2024, 1:59 PM EDT) -- NEW YORK — Suboxone maker Indivior has agreed to a $86 million settlement with multiple states to settle allegations that its buprenorphine-based products that are used to treat opioid use disorder but can fuel addiction if misused helped spread “deadly opioid addictions across New York and the country,” the New York attorney general announced July 26 in a press release....